RecruitingPhase 3ACTRN12605000082606
INSTEP Trial
Influence of NSAID on Short Term Efficacy of Pleurodesis for recurrent pneumothorax
Sponsor
Gavin M Wright
Enrollment
100 participants
Start Date
Dec 15, 2004
Study Type
Interventional
Conditions
Summary
For pain relief after VATS pleurodesis, patients are given either Celebrex or Placebo for 5 days plus any other required analgesics. We aim to determine whether there is any difference in failure of the lung to adhere to the lining of the chest.
Eligibility
Sex: Both males and femalesMin Age: 18 Yearss
Inclusion Criteria1
- Patients with surgical indication for pleurodesis due to recurrent or persistent pneumohtorax
Exclusion Criteria2
- Chronic NSAID usage that cannot be stopped for more than 24 hours prior to surgery.
- Renal impairment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Celebrex 200mg bd 5 days
Celebrex 200mg bd 5 days
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000082606